32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A 29 nucleotide deletion in open reading frame 8 (ORF8) is the most obvious genetic change in severe acute respiratory syndrome coronavirus (SARS-CoV) during its emergence in humans. In spite of intense study, it remains unclear whether the deletion actually reflects adaptation to humans. Here we engineered full, partially deleted (−29 nt), and fully deleted ORF8 into a SARS-CoV infectious cDNA clone, strain Frankfurt-1. Replication of the resulting viruses was compared in primate cell cultures as well as Rhinolophus bat cells made permissive for SARS-CoV replication by lentiviral transduction of the human angiotensin-converting enzyme 2 receptor. Cells from cotton rat, goat, and sheep provided control scenarios that represent host systems in which SARS-CoV is neither endemic nor epidemic. Independent of the cell system, the truncation of ORF8 (29 nt deletion) decreased replication up to 23-fold. The effect was independent of the type I interferon response. The 29 nt deletion in SARS-CoV is a deleterious mutation acquired along the initial human-to-human transmission chain. The resulting loss of fitness may be due to a founder effect, which has rarely been documented in processes of viral emergence. These results have important implications for the retrospective assessment of the threat posed by SARS.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

          The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. The novel coronavirus might have a role in causing SARS. Copyright 2003 Massachusetts Medical Society
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global trends in emerging infectious diseases

            The next new disease Emerging infectious diseases are a major threat to health: AIDS, SARS, drug-resistant bacteria and Ebola virus are among the more recent examples. By identifying emerging disease 'hotspots', the thinking goes, it should be possible to spot health risks at an early stage and prepare containment strategies. An analysis of over 300 examples of disease emerging between 1940 and 2004 suggests that these hotspots can be accurately mapped based on socio-economic, environmental and ecological factors. The data show that the surveillance effort, and much current research spending, is concentrated in developed economies, yet the risk maps point to developing countries as the more likely source of new diseases. Supplementary information The online version of this article (doi:10.1038/nature06536) contains supplementary material, which is available to authorized users.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.

              Y Guan (2003)
              A novel coronavirus (SCoV) is the etiological agent of severe acute respiratory syndrome (SARS). SCoV-like viruses were isolated from Himalayan palm civets found in a live-animal market in Guangdong, China. Evidence of virus infection was also detected in other animals (including a raccoon dog, Nyctereutes procyonoides) and in humans working at the same market. All the animal isolates retain a 29-nucleotide sequence that is not found in most human isolates. The detection of SCoV-like viruses in small, live wild mammals in a retail market indicates a route of interspecies transmission, although the natural reservoir is not known.
                Bookmark

                Author and article information

                Contributors
                christian.drosten@charite.de
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                11 October 2018
                11 October 2018
                2018
                : 8
                : 15177
                Affiliations
                [1 ]Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Charitéplatz 1, 10117 Berlin, Germany
                [2 ]GRID grid.452463.2, German Center for Infection Research (DZIF), ; Berlin, Germany
                [3 ]ISNI 0000 0000 8786 803X, GRID grid.15090.3d, Institute of Virology, , University of Bonn Medical Centre, ; Sigmund-Freud-Str. 25, 53127 Bonn, Germany
                [4 ]Federal Department of Home Affairs, Institute of Virology and Immunology IVI, Bern and Mittelhäusern, Sensemattstrasse 293, 3147 Mittelhäusern, Switzerland
                [5 ]ISNI 0000 0001 0726 5157, GRID grid.5734.5, Department of Infectious Diseases and Pathobiology, , Vetsuisse Faculty, University of Bern, ; Länggassstrasse 122, 3012 Bern, Switzerland
                [6 ]Noctalis, Centre for Bat Protection and Information, Oberbergstraße 27, 23795 Bad Segeberg, Germany
                [7 ]ISNI 0000 0004 1757 1758, GRID grid.6292.f, Dipartimento di Scienze Mediche Veterinarie, , Facoltà di Medicina Veterinaria, Alma Mater Studiorum-Università di Bologna, ; Via Tolara di Sopra 50, 40064 Ozzano Emilia, (BO) Italy
                [8 ]ISNI 0000 0001 0721 6013, GRID grid.8954.0, Virology Unit, Institute of Microbiology and Parasitology, , Veterinary Faculty, University of Ljubljana, ; Gerbičeva 60, 1000 Ljubljana, Slovenia
                [9 ]ISNI 0000 0004 1936 9748, GRID grid.6582.9, Institute of Evolutionary Ecology and Conservation Genomics, , University of Ulm, ; Albert-Einstein Allee 11, 89069 Ulm, Germany
                [10 ]Group Morcegos de Galicia, Drosera Society, Pdo. Magdalena, G-2, 2° esq, 15320 As Pontes, Spain
                [11 ]ISNI 0000 0001 2240 3300, GRID grid.10388.32, Institute for Pharmacology and Toxicology, , University of Bonn, ; Sigmund-Freud-Str. 25, 53127 Bonn, Germany
                Author information
                http://orcid.org/0000-0002-3605-0136
                http://orcid.org/0000-0003-0320-2743
                http://orcid.org/0000-0002-8049-6645
                http://orcid.org/0000-0003-2242-5117
                Article
                33487
                10.1038/s41598-018-33487-8
                6181990
                30310104
                3653e363-e0e6-4339-b486-df12d541d204
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 16 July 2018
                : 27 September 2018
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft (German Research Foundation);
                Award ID: DFG DR 772/12-1
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100007601, EC | Horizon 2020 (European Union Framework Programme for Research and Innovation);
                Award ID: 643476
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Uncategorized
                Uncategorized

                Comments

                Comment on this article